COEP
Price
$14.15
Change
-$0.36 (-2.48%)
Updated
Nov 13 closing price
Capitalization
69.08M
Intraday BUY SELL Signals
JSPR
Price
$1.60
Change
-$0.01 (-0.62%)
Updated
Nov 14, 12:24 PM (EDT)
Capitalization
44.77M
Intraday BUY SELL Signals
Interact to see
Advertisement

COEP vs JSPR

Header iconCOEP vs JSPR Comparison
Open Charts COEP vs JSPRBanner chart's image
Coeptis Therapeutics Holdings
Price$14.15
Change-$0.36 (-2.48%)
Volume$17.66K
Capitalization69.08M
Jasper Therapeutics
Price$1.60
Change-$0.01 (-0.62%)
Volume$100
Capitalization44.77M
COEP vs JSPR Comparison Chart in %
COEP
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COEP vs. JSPR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a StrongBuy and JSPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (COEP: $14.15 vs. JSPR: $1.61)
Brand notoriety: COEP and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 37% vs. JSPR: 117%
Market capitalization -- COEP: $69.08M vs. JSPR: $44.77M
COEP [@Biotechnology] is valued at $69.08M. JSPR’s [@Biotechnology] market capitalization is $44.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 1 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 1 green, 4 red.
According to our system of comparison, JSPR is a better buy in the long-term than COEP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 3 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • COEP’s TA Score: 3 bullish, 5 bearish.
  • JSPR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than COEP.

Price Growth

COEP (@Biotechnology) experienced а +1.43% price change this week, while JSPR (@Biotechnology) price change was -12.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COEP($69.1M) has a higher market cap than JSPR($44.8M). COEP YTD gains are higher at: 157.273 vs. JSPR (-92.470). COEP has higher annual earnings (EBITDA): -11.18M vs. JSPR (-92.73M). JSPR has more cash in the bank: 39.5M vs. COEP (2.99M). COEP has less debt than JSPR: COEP (1.33M) vs JSPR (2.16M). COEP has higher revenues than JSPR: COEP (264K) vs JSPR (0).
COEPJSPRCOEP / JSPR
Capitalization69.1M44.8M154%
EBITDA-11.18M-92.73M12%
Gain YTD157.273-92.470-170%
P/E RatioN/AN/A-
Revenue264K0-
Total Cash2.99M39.5M8%
Total Debt1.33M2.16M62%
FUNDAMENTALS RATINGS
COEP vs JSPR: Fundamental Ratings
COEP
JSPR
OUTLOOK RATING
1..100
6273
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3795
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JSPR's Valuation (34) in the null industry is in the same range as COEP (63). This means that JSPR’s stock grew similarly to COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (93) in the null industry is in the same range as JSPR (100). This means that COEP’s stock grew similarly to JSPR’s over the last 12 months.

JSPR's SMR Rating (99) in the null industry is in the same range as COEP (100). This means that JSPR’s stock grew similarly to COEP’s over the last 12 months.

COEP's Price Growth Rating (37) in the null industry is somewhat better than the same rating for JSPR (95). This means that COEP’s stock grew somewhat faster than JSPR’s over the last 12 months.

JSPR's P/E Growth Rating (4) in the null industry is significantly better than the same rating for COEP (100). This means that JSPR’s stock grew significantly faster than COEP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPJSPR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
63%
Bullish Trend 25 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AP2.170.26
+13.61%
Ampco-Pittsburgh Corp
BDULF0.56N/A
N/A
Bangkok Dusit Medical Services Public Co., Ltd.
CIMEF0.82N/A
N/A
CIMC Enric Holdings Ltd.
NTNOF0.60N/A
N/A
NORTHERN OCEAN LTD
CERS1.60-0.05
-3.03%
Cerus Corp

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TAOX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
-2.48%
TAOX - COEP
37%
Loosely correlated
-13.28%
TVRD - COEP
32%
Poorly correlated
-3.07%
SCNI - COEP
31%
Poorly correlated
-8.68%
TIL - COEP
31%
Poorly correlated
-7.20%
JSPR - COEP
28%
Poorly correlated
-9.04%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-9.04%
AUPH - JSPR
44%
Loosely correlated
-2.06%
ETHZ - JSPR
38%
Loosely correlated
-4.88%
AVXL - JSPR
35%
Loosely correlated
-17.54%
DSGN - JSPR
34%
Loosely correlated
-7.23%
APGE - JSPR
34%
Loosely correlated
-0.21%
More